Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study

Our objective was to predict the outcome of peptide receptor radionuclide therapy (PRRT) using multimodality imaging and tumor dosimetry on gastroenteropancreatic neuroendocrine tumor (GEP-NET) lesions and patients. Methods: This prospective study included patients with progressive GEP-NETs. Treatme...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 2024-02, Vol.65 (2), p.236-244
Hauptverfasser:	Mileva, Magdalena, Marin, Gwennaëlle, Levillain, Hugo, Artigas, Carlos, Van Bogaert, Camille, Marin, Clémentine, Danieli, Rachele, Deleporte, Amelie, Picchia, Simona, Stathopoulos, Konstantinos, Jungels, Christiane, Vanderlinden, Bruno, Paesmans, Marianne, Ameye, Lieveke, Critchi, Gabriela, Taraji-Schiltz, Loubna, Velghe, Chloe, Wimana, Zéna, Bali, Maria, Hendlisz, Alain, Flamen, Patrick, Karfis, Ioannis
Format:	Artikel
Sprache:	eng
Schlagworte:	Computed tomography Diffusion coefficient Diffusion rate Dosimeters Dosimetry Glycolysis Health hazards Lesions Lutetium isotopes Mean Median (statistics) Medical imaging Neuroendocrine tumors Parameters Patients Positron emission Positron emission tomography Radiation therapy Radioisotopes Receptors Single photon emission computed tomography Somatostatin Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!